(Toe, Ankle, Sole, Heel and Arch)
Diabetes, a severe health challenge, which deeply impacts personal lifestyles, individual finances, and national healthcare expenditures.
415 million people worldwide are living with diabetes.
4.8 million diabetics in the UK.
1 in 10 people in the US have diabetes.
In the US, an estimated $245Billion is spent of direct and indirect medical costs. Annual US burden of diabetic foot ulcers is $15 Billion.
In the UK, £10 Billion is spent by the NHS every year.
Up to 25% of those with diabetes will develop a foot ulcer.
8793 diabetes related amputations in the UK every year.
People with diabetes deserve efficient, tailored monitoring and treatment plans for their diabetic foot ulcers.
TASHA's advanced technology enables real-time monitoring, breaking down access barriers, cutting GP visit costs, and facilitating quick ulcer detection by healthcare professionals.
TASHA's advanced tracking continuously monitors ulcer changes for early detection and progression. This proactive method ensures timely interventions and personalized treatments for the best patient healing outcomes.
AI predictive modeling analyzes data patterns for foresight on ulcer trends. This system alerts clinicians to prioritize patients needing earlier reviews, rather than adhering to standard schedules, optimizing patient outcomes.
Central to MIG's ethos, T.A.S.H.A drives our mission to reduce the tragic toll of diabetes. We envision a brighter, efficient future for diabetic patients worldwide.